Technical Analysis of Stocks: SPY / QQQ / NVDA / TSLA / AMD / PLTR / HOOD

AI-generated source summary

The analysis focuses on the potential continuation of the bullish trend in the S&P 500 ETF (SPY), Nasdaq 100 ETF (QQQ), and NVIDIA (NVDA). The speaker identified a double bottom pattern on QQQ, suggesting a potential upward movement. For SPY and QQQ, the analysis indicates that they are approaching previous resistance levels and are expected to break out to new all-time highs. However, the speaker cautions about the need for careful risk management, especially for NVDA, which has shown a slightly weaker reaction to the identified bullish signals. The 21-day moving average on SPY and QQQ is noted as a key support level, with the price action currently above it. For NVDA, the 209.70 mark is identified as a critical resistance level. The overarching sentiment is bullish, with a focus on further upside potential provided these levels hold. The analysis emphasizes that market behavior is reactive, and trade decisions should be based on observed price action and established technical patterns, with a keen eye on risk-reward ratios.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   15 Jun 2026, 22:00 UTC

   The analyst published the original source item.

2. Source recorded by Tahlil Plus

   15 Jun 2026, 22:52 UTC

   The public source was preserved as the evidence record for this case.

3. Market predictions extracted

   15 Jun 2026, 22:53 UTC

   2 eligible signals linked to this case.

4. Source processing completed

   15 Jun 2026, 22:53 UTC

   Source analysis and structured extraction completed.

5. Outcome tracking started

   16 Jun 2026, 01:01 UTC

   Tahlil Plus began monitoring the extracted predictions.

6. First prediction resolved

   17 Jun 2026, 01:01 UTC

   The first evaluable outcome in this case reached a terminal result.

7. Case evaluation completed

   17 Jun 2026, 01:31 UTC

   All evaluable predictions in this case reached terminal outcomes.